Skip to Content

Notice

Office of the Director; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to Pub. L. 92-463, notice is hereby given of a meeting of the Advisory Committee to the Director, NIH.

The entire meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the Contact Person listed below in advance of the meeting. The meeting will take place via conference call with the members. A speaker phone will be installed in the conference room for the public to listen to the discussion.

Name of Committee: Advisory Committee to the Director, NIH.

Date: September 14, 2000.

Time: 4-5 p.m.

Agenda: To discuss and provide advice on the final Report from the Working Group on NIH Oversight of Clinical Gene Transfer Research.

Place: National Institutes of Health, 1 Center Drive, Building 1, Room 151, Bethesda, Maryland 20892.

Contact: Ms. Janice C. Ramsden, Special Assistant to the Principal Deputy Director, NIH, National Institutes of Health, Building 1, Room 235, Bethesda, Maryland 20892, jr52h@nih.gov, Telephone: (301) 496-0959.

Start Signature

Dated: August 4, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 00-20371 Filed 8-10-00; 8:45 am]

BILLING CODE 4140-01-M